CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.3195
+0.0020 (0.63%)
May 6, 2026, 3:41 PM EST
CytoDyn Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
408.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | - | - | - |
| May 31, 2024 | - | - | - |
| May 31, 2023 | - | - | - |
| May 31, 2022 | 266.00K | - | - |
| May 31, 2021 | - | - | - |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaxart | 237.26M |
| BioStem Technologies | 47.48M |
| Nuo Therapeutics | 3.31M |
| Northwest Biotherapeutics | 1.38M |
| Silence Therapeutics | 559.00K |
CytoDyn News
- 6 days ago - CytoDyn Transcript: Study update - Transcripts
- 9 days ago - CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer - GlobeNewsWire
- 13 days ago - CytoDyn to Host Investor Webcast - GlobeNewsWire
- 14 days ago - CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 - GlobeNewsWire
- 15 days ago - CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study - GlobeNewsWire
- 16 days ago - CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 - GlobeNewsWire
- 22 days ago - CytoDyn to Present at the AACR Annual Meeting 2026 - GlobeNewsWire
- 6 weeks ago - CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer - GlobeNewsWire